{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-074952","form_type":"8-K","ticker":"HRTX","cik":"0000818033","company_name":"HERON THERAPEUTICS, INC. /DE/","filed_at":"2024-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.067711+00:00","generated_at":"2026-06-01T04:00:28.553278+00:00","sec_items":["5.02","5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Heron shareholders approve increase in authorized shares to 400M and equity plan share expansion","bullets":["Authorized common stock increased by 175M shares from 225M to 400M; effective June 13, 2024.","2007 Plan shares increased by 7.5M (from 39.19M to 46.69M) and ESPP shares by 1.2M (from 2.225M to 3.425M).","All six director nominees elected with ~87M votes for each; auditor ratified with ~114M votes for.","Say-on-pay advisory vote passed with 72.7M for vs 14.4M against; broker non-votes of 29.2M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-074952","json":"https://secwatch.observer/filing/0000950170-24-074952.json","markdown":"https://secwatch.observer/filing/0000950170-24-074952.md","text":"https://secwatch.observer/filing/0000950170-24-074952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818033/000095017024074952/0000950170-24-074952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818033/000095017024074952/hrtx-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:00:28.553278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}